Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altering Activation Patterns in the Distal Upper Extremity After Stroke
NCT02418949Completed
- Sponsor
- Shirley Ryan AbilityLab
- Start
- Nov 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of cyproheptadine in stroke, Spasticity and hemiparesis (4 arms), sponsored by Shirley Ryan AbilityLab. Primary endpoint: Mean Completion Time for Graded Wolf Motor Function Test at 9 weeks. Started Nov 2015; status: completed.
02
Drugs
cyproheptadine
03
Conditions
strokeSpasticityhemiparesis
Beyond the preview
Go deeper on NCT02418949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418949.